Transcription Factor ETS-1 and Reactive Oxygen Species: Role in Vascular and Renal Injury
Abstract
:1. Introduction
2. Regulation
2.1. Posttranslational Modifications
2.2. By Transcription Factors
2.3. By Nuclear Transport
2.4. Regulation of Its Expression
3. Effects of Angiotensin II on ETS-1 Expression and the Functional Consequences in the Vasculature and Kidney
3.1. In Vitro Studies
3.2. In Vivo Studies
4. ETS-1 in Neointima Formation
5. ETS-1 in Salt-Sensitive Hypertension
6. Conclusions
Funding
Acknowledgments
Conflicts of Interest
References
- Leprince, D.; Gegonne, A.; Coll, J.; de Taisne, C.; Schneeberger, A.; Lagrou, C.; Stehelin, D. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 1983, 306, 395–397. [Google Scholar] [CrossRef] [PubMed]
- Nunn, M.F.; Seeburg, P.H.; Moscovici, C.; Duesberg, P.H. Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature 1983, 306, 391–395. [Google Scholar] [CrossRef] [PubMed]
- Watson, D.K.; McWilliams-Smith, M.J.; Nunn, M.F.; Duesberg, P.H.; O’Brien, S.J.; Papas, T.S. The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: Both loci are transcriptionally active. Proc. Natl. Acad. Sci. USA 1985, 82, 7294–7298. [Google Scholar] [CrossRef] [PubMed]
- Hollenhorst, P.C.; McIntosh, L.P.; Graves, B.J. Genomic and biochemical insights into the specificity of ETS transcription factors. Ann. Rev. Biochem. 2011, 80, 437–471. [Google Scholar] [CrossRef] [PubMed]
- Findlay, V.J.; LaRue, A.C.; Turner, D.P.; Watson, P.M.; Watson, D.K. Understanding the role of ETS-mediated gene regulation in complex biological processes. Adv. Cancer Res. 2013, 119, 1–61. [Google Scholar] [PubMed]
- Iotsova, V.; Crepieux, P.; Montpellier, C.; Laudet, V.; Stehelin, D. TATA-less promoters of some Ets-family genes are efficiently repressed by wild-type p53. Oncogene 1996, 13, 2331–2337. [Google Scholar] [PubMed]
- Garrett-Sinha, L.A. Review of Ets1 structure, function, and roles in immunity. Cell. Mol. Life Sci. 2013, 70, 3375–3390. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dittmer, J. The biology of the Ets1 proto-oncogene. Mol. Cancer 2003, 2, 29. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yang, B.S.; Hauser, C.A.; Henkel, G.; Colman, M.S.; Van Beveren, C.; Stacey, K.J.; Hume, D.A.; Maki, R.A.; Ostrowski, M.C. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 1996, 16, 538–547. [Google Scholar] [CrossRef] [PubMed]
- Slupsky, C.M.; Gentile, L.N.; Donaldson, L.W.; Mackereth, C.D.; Seidel, J.J.; Graves, B.J.; McIntosh, L.P. Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site. Proc. Natl. Acad. Sci. USA 1998, 95, 12129–12134. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wasylyk, B.; Hagman, J.; Gutierrez-Hartmann, A. Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem. Sci. 1998, 23, 213–216. [Google Scholar] [CrossRef]
- Foulds, C.E.; Nelson, M.L.; Blaszczak, A.G.; Graves, B.J. Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Mol. Cell. Biol. 2004, 24, 10954–10964. [Google Scholar] [CrossRef] [PubMed]
- Nelson, M.L.; Kang, H.S.; Lee, G.M.; Blaszczak, A.G.; Lau, D.K.; McIntosh, L.P.; Graves, B.J. Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP. Proc. Natl. Acad. Sci. USA 2010, 107, 10026–10031. [Google Scholar] [CrossRef] [PubMed]
- Czuwara-Ladykowska, J.; Sementchenko, V.I.; Watson, D.K.; Trojanowska, M. Ets1 is an effector of the transforming growth factor beta (TGF-beta) signaling pathway and an antagonist of the profibrotic effects of TGF-beta. J. Biol. Chem. 2002, 277, 20399–20408. [Google Scholar] [CrossRef] [PubMed]
- Cowley, D.O.; Graves, B.J. Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition. Genes Dev. 2000, 14, 366–376. [Google Scholar] [PubMed]
- Nishida, T.; Terashima, M.; Fukami, K.; Yamada, Y. PIASy controls ubiquitination-dependent proteasomal degradation of Ets-1. Biochem. J. 2007, 405, 481–488. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ji, Z.; Degerny, C.; Vintonenko, N.; Deheuninck, J.; Foveau, B.; Leroy, C.; Coll, J.; Tulasne, D.; Baert, J.L.; Fafeur, V. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation. Oncogene 2007, 26, 395–406. [Google Scholar] [CrossRef] [PubMed]
- Nishida, T.; Terashima, M.; Fukami, K. PIASy-mediated repression of the Ets-1 is independent of its sumoylation. Biochem. Biophys. Res. Commun. 2006, 345, 1536–1546. [Google Scholar] [CrossRef] [PubMed]
- Sieweke, M.H.; Tekotte, H.; Jarosch, U.; Graf, T. Cooperative interaction of Ets-1 with USF-1 required for HIV-1 enhancer activity in T cells. EMBO J. 1998, 17, 1728–1739. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Garvie, C.W.; Hagman, J.; Wolberger, C. Structural studies of Ets-1/Pax5 complex formation on DNA. Mol. Cell. 2001, 8, 1267–1276. [Google Scholar] [CrossRef]
- Tian, G.; Erman, B.; Ishii, H.; Gangopadhyay, S.S.; Sen, R. Transcriptional activation by ETS and leucine zipper-containing basic helix-loop-helix proteins. Mol. Cell. Biol. 1999, 19, 2946–2957. [Google Scholar] [CrossRef] [PubMed]
- Kim, W.Y.; Sieweke, M.; Ogawa, E.; Wee, H.J.; Englmeier, U.; Graf, T.; Ito, Y. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. EMBO J. 1999, 18, 1609–1620. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Goetz, T.L.; Gu, T.L.; Speck, N.A.; Graves, B.J. Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2. Mol. Cell. Biol. 2000, 20, 81–90. [Google Scholar] [CrossRef] [PubMed]
- Fitzsimmons, D.; Lukin, K.; Lutz, R.; Garvie, C.W.; Wolberger, C.; Hagman, J. Highly cooperative recruitment of Ets-1 and release of autoinhibition by Pax5. J. Mol. Biol. 2009, 392, 452–464. [Google Scholar] [CrossRef] [PubMed]
- Baillat, D.; Begue, A.; Stehelin, D.; Aumercier, M. ETS-1 transcription factor binds cooperatively to the palindromic head to head ETS-binding sites of the stromelysin-1 promoter by counteracting autoinhibition. J. Biol. Chem. 2002, 277, 29386–29398. [Google Scholar] [CrossRef] [PubMed]
- Boulukos, K.E.; Pognonec, P.; Rabault, B.; Begue, A.; Ghysdael, J. Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro. Mol. Cell. Biol. 1989, 9, 5718–5721. [Google Scholar] [CrossRef] [PubMed]
- Pearse, D.D.; Tian, R.X.; Nigro, J.; Iorgulescu, J.B.; Puzis, L.; Jaimes, E.A. Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells. Am. J. Physiol. Ren. Physiol. 2008, 294, F1094–F1100. [Google Scholar] [CrossRef] [PubMed]
- Abe, K.; Nakashima, H.; Ishida, M.; Miho, N.; Sawano, M.; Soe, N.N.; Kurabayashi, M.; Chayama, K.; Yoshizumi, M.; Ishida, T. Angiotensin II-induced osteopontin expression in vascular smooth muscle cells involves Gq/11, Ras, ERK, Src and Ets-1. Hypertens. Res. 2008, 31, 987–998. [Google Scholar] [CrossRef] [PubMed]
- Dzau, V.J. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: A unifying hypothesis. Hypertension 2001, 37, 1047–1052. [Google Scholar] [CrossRef] [PubMed]
- Taniyama, Y.; Hitomi, H.; Shah, A.; Alexander, R.W.; Griendling, K.K. Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 1142–1147. [Google Scholar] [CrossRef] [PubMed]
- Nedeljkovic, Z.S.; Gokce, N.; Loscalzo, J. Mechanisms of oxidative stress and vascular dysfunction. Postgrad. Med. J. 2003, 79, 195–199. [Google Scholar] [CrossRef] [PubMed]
- Jaimes, E.A.; Galceran, J.M.; Raij, L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int. 1998, 54, 775–784. [Google Scholar] [CrossRef] [PubMed]
- Goetze, S.; Kintscher, U.; Kaneshiro, K.; Meehan, W.P.; Collins, A.; Fleck, E.; Hsueh, W.A.; Law, R.E. TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. Atherosclerosis 2001, 159, 93–101. [Google Scholar] [CrossRef]
- Hultgardh-Nilsson, A.; Cercek, B.; Wang, J.W.; Naito, S.; Lovdahl, C.; Sharifi, B.; Forrester, J.S.; Fagin, J.A. Regulated expression of the ETS-1 transcription factor in vascular smooth muscle cells in vivo and in vitro. Circ. Res. 1996, 78, 589–595. [Google Scholar] [CrossRef] [PubMed]
- Naito, S.; Shimizu, S.; Maeda, S.; Wang, J.; Paul, R.; Fagin, J.A. Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells. Am. J. Physiol. 1998, 274, C472–C480. [Google Scholar] [CrossRef] [PubMed]
- Zhan, Y.; Brown, C.; Maynard, E.; Anshelevich, A.; Ni, W.; Ho, I.C.; Oettgen, P. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J. Clin. Investig. 2005, 115, 2508–2516. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hua, P.; Feng, W.; Rezonzew, G.; Chumley, P.; Jaimes, E.A. The transcription factor ETS-1 regulates angiotensin II-stimulated fibronectin production in mesangial cells. Am. J. Physiol. Ren. Physiol. 2012, 302, F1418–F1429. [Google Scholar] [CrossRef] [PubMed]
- Wilson, L.A.; Gemin, A.; Espiritu, R.; Singh, G. ETS-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element. FASEB J. 2005, 19, 2085–2087. [Google Scholar] [CrossRef] [PubMed]
- Nelson, K.K.; Subbaram, S.; Connor, K.M.; Dasgupta, J.; Ha, X.F.; Meng, T.C.; Tonks, N.K.; Melendez, J.A. Redox-dependent matrix metalloproteinase-1 expression is regulated by JNK through Ets and AP-1 promoter motifs. J. Biol. Chem. 2006, 281, 14100–14110. [Google Scholar] [CrossRef] [PubMed]
- Landmesser, U.; Cai, H.; Dikalov, S.; McCann, L.; Hwang, J.; Jo, H.; Holland, S.M.; Harrison, D.G. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002, 40, 511–515. [Google Scholar] [CrossRef] [PubMed]
- Jaimes, E.A.; Tian, R.X.; Pearse, D.; Raij, L. Up-regulation of glomerular COX-2 by angiotensin II: Role of reactive oxygen species. Kidney Int. 2005, 68, 2143–2153. [Google Scholar] [CrossRef] [PubMed]
- Zhou, M.S.; Jaimes, E.A.; Raij, L. Vascular but not cardiac remodeling is associated with superoxide production in angiotensin II hypertension. J. Hypertens. 2005, 23, 1737–1743. [Google Scholar] [CrossRef] [PubMed]
- Raffetseder, U.; Wernert, N.; Ostendorf, T.; van Roeyen, C.; Rauen, T.; Behrens, P.; Floege, J.; Mertens, P.R. Mesangial cell expression of proto-oncogene Ets-1 during progression of mesangioproliferative glomerulonephritis. Kidney Int. 2004, 66, 622–632. [Google Scholar] [CrossRef] [PubMed]
- Tanaka, H.; Terada, Y.; Kobayashi, T.; Okado, T.; Inoshita, S.; Kuwahara, M.; Seth, A.; Sato, Y.; Sasaki, S. Expression and function of Ets-1 during experimental acute renal failure in rats. J. Am. Soc. Nephrol. 2004, 15, 3083–3092. [Google Scholar] [CrossRef] [PubMed]
- Naito, T.; Razzaque, M.S.; Nazneen, A.; Liu, D.; Nihei, H.; Koji, T.; Taguchi, T. Renal expression of the Ets-1 proto-oncogene during progression of rat crescentic glomerulonephritis. J. Am. Soc. Nephrol. 2000, 11, 2243–2255. [Google Scholar] [PubMed]
- Feng, W.; Chumley, P.; Hua, P.; Rezonzew, G.; Jaimes, D.; Duckworth, M.W.; Xing, D.; Jaimes, E.A. Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin II. Hypertension 2012, 60, 1226–1233. [Google Scholar] [CrossRef] [PubMed]
- Ni, W.; Zhan, Y.; He, H.; Maynard, E.; Balschi, J.A.; Oettgen, P. Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47(phox) gene expression in response to angiotensin II. Circ. Res. 2007, 101, 985–994. [Google Scholar] [CrossRef] [PubMed]
- Feng, W.; Xing, D.; Hua, P.; Zhang, Y.; Chen, Y.F.; Oparil, S.; Jaimes, E.A. The transcription factor ETS-1 mediates proinflammatory responses and neointima formation in carotid artery endoluminal vascular injury. Hypertension 2010, 55, 1381–1388. [Google Scholar] [CrossRef] [PubMed]
- Feng, W.; Chumley, P.; Allon, M.; George, J.; Scott, D.W.; Patel, R.P.; Litovsky, S.; Jaimes, E.A. The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula. J. Am. Soc. Nephrol. 2014, 25, 475–487. [Google Scholar] [CrossRef] [PubMed]
- Weinberger, M.H.; Miller, J.Z.; Luft, F.C.; Grim, C.E.; Fineberg, N.S. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986, 8, II127–II134. [Google Scholar] [CrossRef] [PubMed]
- Zhou, M.S.; Adam, A.G.; Jaimes, E.A.; Raij, L. In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II. Hypertension 2003, 42, 945–951. [Google Scholar] [CrossRef] [PubMed]
- Navar, L.G.; Harrison-Bernard, L.M.; Nishiyama, A.; Kobori, H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002, 39, 316–322. [Google Scholar] [CrossRef] [PubMed]
- Re, R.N. Intracellular renin and the nature of intracrine enzymes. Hypertension 2003, 42, 117–122. [Google Scholar] [CrossRef] [PubMed]
- Kobori, H.; Ozawa, Y.; Suzaki, Y.; Prieto-Carrasquero, M.C.; Nishiyama, A.; Shoji, T.; Cohen, E.P.; Navar, L.G. Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases. Am. J. Hypertens. 2006, 19, 541–550. [Google Scholar] [CrossRef] [PubMed]
- Kobori, H.; Nangaku, M.; Navar, L.G.; Nishiyama, A. The intrarenal renin-angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol. Rev. 2007, 59, 251–287. [Google Scholar] [CrossRef] [PubMed]
- Ingert, C.; Grima, M.; Coquard, C.; Barthelmebs, M.; Imbs, J.L. Contribution of angiotensin II internalization to intrarenal angiotensin II levels in rats. Am. J. Physiol. Renal Physiol. 2002, 283, F1003–F1010. [Google Scholar] [CrossRef] [PubMed]
- Iwai, J.; Dahl, L.K.; Knudsen, K.D. Genetic influence on the renin-angiotensin system: Low renin activities in hypertension-prone rats. Circ. Res. 1973, 32, 678–684. [Google Scholar] [CrossRef] [PubMed]
- Hayakawa, H.; Coffee, K.; Raij, L. Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: Effects of antihypertensive therapy. Circulation 1997, 96, 2407–2413. [Google Scholar] [CrossRef] [PubMed]
- Kodama, K.; Adachi, H.; Sonoda, J. Beneficial effects of long-term enalapril treatment and low-salt intake on survival rate of dahl salt-sensitive rats with established hypertension. J. Pharmacol. Exp. Ther. 1997, 283, 625–629. [Google Scholar] [PubMed]
- Otsuka, F.; Yamauchi, T.; Kataoka, H.; Mimura, Y.; Ogura, T.; Makino, H. Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats. Am. J. Physiol. 1998, 274, R1797–R1806. [Google Scholar] [CrossRef] [PubMed]
- Hayashida, W.; Kihara, Y.; Yasaka, A.; Inagaki, K.; Iwanaga, Y.; Sasayama, S. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts. J. Mol. Cell. Cardiol. 2001, 33, 733–744. [Google Scholar] [CrossRef] [PubMed]
- Sakata, Y.; Masuyama, T.; Yamamoto, K.; Doi, R.; Mano, T.; Kuzuya, T.; Miwa, T.; Takeda, H.; Hori, M. Renin angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats: Different characteristics from renin angiotensin system-independent hypertrophy. J. Am. Coll. Cardiol. 2001, 37, 293–299. [Google Scholar] [CrossRef]
- Nishikimi, T.; Mori, Y.; Kobayashi, N.; Tadokoro, K.; Wang, X.; Akimoto, K.; Yoshihara, F.; Kangawa, K.; Matsuoka, H. Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats. Hypertension 2002, 39, 1077–1082. [Google Scholar] [CrossRef] [PubMed]
- Kobori, H.; Nishiyama, A.; Abe, Y.; Navar, L.G. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 2003, 41, 592–597. [Google Scholar] [CrossRef] [PubMed]
- Nishiyama, A.; Yoshizumi, M.; Rahman, M.; Kobori, H.; Seth, D.M.; Miyatake, A.; Zhang, G.X.; Yao, L.; Hitomi, H.; Shokoji, T.; et al. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int. 2004, 65, 972–981. [Google Scholar] [CrossRef] [PubMed]
- Onozato, M.L.; Tojo, A.; Kobayashi, N.; Goto, A.; Matsuoka, H.; Fujita, T. Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney. Nephrol. Dial. Transplant. 2007, 22, 1314–1322. [Google Scholar] [CrossRef] [PubMed]
- Feng, W.; Chumley, P.; Prieto, M.C.; Miyada, K.; Seth, D.M.; Fatima, H.; Hua, P.; Rezonzew, G.; Sanders, P.W.; Jaimes, E.A. Transcription factor avian erythroblastosis virus E26 oncogen homolog-1 is a novel mediator of renal injury in salt-sensitive hypertension. Hypertension 2015, 65, 813–820. [Google Scholar] [CrossRef] [PubMed]
- Zhou, M.S.; Hernandez Schulman, I.; Pagano, P.J.; Jaimes, E.A.; Raij, L. Reduced NAD(P)H oxidase in low renin hypertension: Link among angiotensin II, atherogenesis, and blood pressure. Hypertension 2006, 47, 81–86. [Google Scholar] [CrossRef] [PubMed]
- Elbashir, S.M.; Harborth, J.; Weber, K.; Tuschl, T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002, 26, 199–213. [Google Scholar] [CrossRef]
- Meng, S.; Roberts, L.J., 2nd; Cason, G.W.; Curry, T.S.; Manning, R.D., Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283, R732–R738. [Google Scholar] [CrossRef] [PubMed]
- Feng, W.; Chen, B.; Xing, D.; Li, X.; Fatima, H.; Jaimes, E.A.; Sanders, P.W. Haploinsufficiency of the Transcription Factor Ets-1 Is Renoprotective in Dahl Salt-Sensitive Rats. J. Am. Soc. Nephrol. 2017, 28, 3239–3250. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Shiu, Y.-T.; Jaimes, E.A. Transcription Factor ETS-1 and Reactive Oxygen Species: Role in Vascular and Renal Injury. Antioxidants 2018, 7, 84. https://doi.org/10.3390/antiox7070084
Shiu Y-T, Jaimes EA. Transcription Factor ETS-1 and Reactive Oxygen Species: Role in Vascular and Renal Injury. Antioxidants. 2018; 7(7):84. https://doi.org/10.3390/antiox7070084
Chicago/Turabian StyleShiu, Yan-Ting, and Edgar A. Jaimes. 2018. "Transcription Factor ETS-1 and Reactive Oxygen Species: Role in Vascular and Renal Injury" Antioxidants 7, no. 7: 84. https://doi.org/10.3390/antiox7070084